EUVIMEDEUVIMED entdecken
Crossref

2278-P: Rising Global Burden of Cancers Attributable to High Fasting Plasma Glucose: Insights from the Global Burden of Disease Study, 1990–2023

HARDIK DINESHBHAI DESAI, ANKITHA VANAPARTI, MANSHA GUPTA, MOUNIKA KOTTE, SAI VARUN GADDE, MUHAMMAD USMAN GHANI, SIRI VUMMANENI

Diabetes · 05.06.2026 · 75 (Supplement_1)

DOI: 10.2337/db26-2278-p ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von HARDIK DINESHBHAI DESAI und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: High fasting plasma glucose (HFPG) contributes to global cancer burden but its long-term impact remains incompletely defined. We quantified temporal trends of neoplasms attributable to HFPG from 1990-2023.

Methods

We estimated cancer deaths and DALYs attributable to HFPG using GBD 2023 across 204 countries, stratified by age, sex, cancer type, and region. Population attributable fractions were calculated using comparative risk assessment. Annual percent change was assessed via log-linear regression.

Results

HFPG-attributable neoplasm deaths increased from 172,171 (95% UI 116,960-249,038) in 1990 to 432,794 (331,702-564,815) in 2023 (EAPC: 2.72%), while DALYs rose from 4.20 to 9.59 million (EAPC: 2.39%). Age-standardized rates declined modestly (deaths: −0.06%; DALYs: −0.20%). In 2023, deaths concentrated in high-income regions 39.3%, Southeast/East Asia 29.7%, and Central/Eastern Europe 8.9%. Pancreatic cancer showed highest increases 3.31%, followed by liver 3.24%, breast 2.48%, colorectal 2.20%, and lung cancer 2.15%. Males experienced declining rates −0.16%; females remained stable 0.02%.

Conclusion

Rising absolute cancer burden despite stable age-standardized rates reflects population aging in high-income and Asian regions. Disproportionate pancreatic and hepatic cancer increases emphasize urgent need for targeted glycemic control strategies as critical cancer prevention. Disclosure H. Desai: None. A. Vanaparti: None. M. Gupta: None. M. Kotte: None. S. Gadde: None. M. Ghani: None. S. Vummaneni: None.

Zitieren

APA

DESAI, H. D., VANAPARTI, A., GUPTA, M., KOTTE, M., GADDE, S. V., GHANI, M. U., & VUMMANENI, S. (2026). 2278-P: Rising Global Burden of Cancers Attributable to High Fasting Plasma Glucose: Insights from the Global Burden of Disease Study, 1990–2023. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2278-p

Vancouver

DESAI HD, VANAPARTI A, GUPTA M, KOTTE M, GADDE SV, GHANI MU, et al. 2278-P: Rising Global Burden of Cancers Attributable to High Fasting Plasma Glucose: Insights from the Global Burden of Disease Study, 1990–2023. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2278-p

BibTeX
@article{DESAI2026,
  author = {DESAI, HARDIK DINESHBHAI and VANAPARTI, ANKITHA and GUPTA, MANSHA and KOTTE, MOUNIKA and GADDE, SAI VARUN and GHANI, MUHAMMAD USMAN and VUMMANENI, SIRI},
  title = {2278-P: Rising Global Burden of Cancers Attributable to High Fasting Plasma Glucose: Insights from the Global Burden of Disease Study, 1990–2023},
  journal = {Diabetes},
  year = {2026},
  volume = {75},
  number = {Supplement_1},
  doi = {10.2337/db26-2278-p}
}
Kostenlos starten →